Lb Pharmaceuticals (LBRX) Other Non-Current Assets (2024 - 2026)

Lb Pharmaceuticals' Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $776000.0 for Q1 2026.

• On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $776000.0 in Q1 2026; TTM through Mar 2026 was $776000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $770000.0, up 54.62% from the prior year.
• Other Non-Current Assets improved to $776000.0 in Q1 2026 per LBRX's latest filing, from $770000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $776000.0 in Q1 2026 and bottomed at $498000.0 in Q4 2024.
• The 3-year median for Other Non-Current Assets is $641000.0 (2025), against an average of $639000.0.
• Biggest YoY gain for Other Non-Current Assets was 54.62% in 2025; the steepest drop was 54.62% in 2025.
• Year by year, Other Non-Current Assets stood at $498000.0 in 2024, then jumped by 54.62% to $770000.0 in 2025, then rose by 0.78% to $776000.0 in 2026.
• Per Business Quant, the three latest LBRX Other Non-Current Assets figures stand at $776000.0 (Q1 2026), $770000.0 (Q4 2025), and $512000.0 (Q3 2025).